Greater Attention Paid to the Patient's Experience Could Improve the Treatment of Individuals With Opioid Use Disorder Hospitalized for Serious Infections.

Journal of Addiction Medicine
Joji Suzuki

Abstract

: There is a growing recognition for the need to improve the treatment of individuals with opioid use disorder who are hospitalized for serious infections such as infective endocarditis. Unfortunately, patients face enormous hurdles not only in coping with the life-threatening medical illness, but also in maintaining their recovery and engagement with treatment due in part to the difficulties navigating the fragmented addiction treatment system. The journey mapping research presented by Bearnot and Mitton is a novel approach that has the potential to improve our understanding of the challenges faced by patients. Given the severe health consequences that can result from these infections, more research is clearly needed to improve the treatment we currently provide. The journey mapping approach appears to be a useful method of incorporating the patient voice in order to improve our understanding of their experience, but also help identify how we can provide treatments that are acceptable and preferred by patients.

References

Aug 5, 2014·JAMA Internal Medicine·Jane M LiebschutzMichael Stein
Oct 22, 2014·JAMA : the Journal of the American Medical Association·Dimitry S Davydow, Wayne J Katon
Oct 26, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Laura R MarksMichael J Durkin
Jan 18, 2019·Journal of Addiction Medicine·Richard Saitz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nursing Older People
Jane Gallagher
Journal of the American College of Cardiology
Lynne Warner Stevenson, Eldrin Lewis
Journal of the American Geriatrics Society
Dalane W Kitzman
Nursing New Zealand = Kai Tiaki
Raelee Jensen
Medical Teacher
Seilesh Kadambari
© 2021 Meta ULC. All rights reserved